Onyx Biotec IPO Review - Issue Date, Price, GMP, Subscription, Allotment, Lot Size, and Details

Onyx Biotec Limited IPO GMP

Onyx Biotec Ltd. is a leading pharmaceutical company engaged in the manufacture and sale distribution of generic and proprietary pharmaceutical products.
Onyx Biotec Ltd. established in 2009, develops, manufactures and distributes generic and branded pharmaceutical products in various forms like (WFI) Water for Injection, Dry Powder Injections, Dry Powder Syrup.

Onyx Biotec
, an Fixed Price Issue amounting to
 ₹29.34 Crores, consisting entirely an Fresh Issue of 48.1 Lakh Shares. The subscription period for the Onyx Biotec IPO opens on November 13, 2024, and closes on November 18, 2024. The allotment is expected to be finalized on or about Tuesday, November 19, 2024, and the shares will be listed on the NSE SME with a tentative listing date set on or about Friday, November 22, 2024.

The Share price of Onyx Biotec IPO is set at ₹58 to 61 per equity share. The Market Capitalisation of the Onyx Biotec Limited at IPO price of ₹61 per equity share will be ₹110.60 Crores. The lot size of the IPO is 2,000 shares. Retail investors are required to invest a minimum of ₹1,22,000, while the minimum investment for High-Net-Worth Individuals (HNIs) is 2 lots (4,000 shares), amounting to ₹2,44,000.

Horizon Management Private Limited is the book-running lead manager while MAS SERVICES LIMITED is the registrar for the Issue. Giriraj Stock Broking Private Limited is the Market Maker for the Onyx Biotec IPO.

Onyx Biotec Limited IPO GMP Today
The Grey Market Premium of Onyx Biotec Limited IPO is expected to be ₹0 based on the financial performance of the company. No real trading is done on the basis of Grey Market Premium that's why no real discovery of price can be done before the listing of shares on the stock exchange. The Grey Market Premium totally depends upon the Demand and Supply of the shares of the company in unorganized manner which is not recommended. The Grey Market Premium is mentioned for educational and informational purposes only.

Onyx Biotec Limited IPO Live Subscription Status Today: Real-Time Updates
As of 07:10 PM on 18 November 2024, the Onyx Biotec IPO live subscription status shows that the IPO subscribed 184.60 times on its Final day of subscription period. Check the Onyx Biotec IPO Live Subscription Status today at NSE.

Onyx Biotec Limited IPO Anchor Investors Report
Onyx Biotec Exports has raised ₹8.33 Crore from Anchor Investors at a price of ₹61 per shares in consultation of the Book Running Lead Managers. The company allocated 13,66,000 equity shares to the Anchor Investors. Check Full List of Onyx Biotec Anchor Investor List.

Note:- Equity Shares allotted to Anchor Investors (if any) are allotted from Qualified Institutional Buyers (QIBs) reservation portion.
Note:- The Number of shares offered shown IPO subscription section table is calculated at the lower end of the price band and Number of shares calculated in IPO details table section is calculated at upper end of the price band in case of Book Building Issue, so there can be difference. This is because we assume shares will be issued by the company at upper band as Anchor Investors also subscribe at upper band and shares will be issued at lower band only if in case of undersubscription of IPO.
Note:- Market Maker portion (if any) are not shown separately in subscription table and included in NIIs reservation portion.

Onyx Biotec Limited IPO Allotment Date - Step by Step Guide to Check Allotment Status Online s
Onyx Biotec IPO allotment date is 19 November, 2024, Tuesday. Onyx Biotec IPO Allotment will be out on 19th November 2024 and will be live on Registrar Website from the allotment date. Check Onyx Biotec IPO Allotment Status here. Here's how you can check the allotment status:
- Navigate to the IPO allotment status page.
- Select Onyx Biotec Limited IPO from the dropdown list of IPOs.
- Enter your application number, PAN, or DP Client ID.
- Submit the details to check your allotment status.
By following either of these methods, investors can quickly determine their allotment status and proceed accordingly with their investments.






Objectives of Onyx Biotec Limited IPO
Onyx Biotec Issue Proceeds from the Fresh Issue will be utilized towards the following objects : 
1. 607.70 Lakhs is required for the Upgradation of existing manufacturing Unit I to manufacture large volume parentals for intravenous use;
2. 
124.05 Lakhs is required for the Setting up a high-speed cartooning packaging line at existing manufacturing Unit II for Dry Powder Injections;
3. 1,200.00 Lakhs is required for the Prepayment or repayment of all or a portion of certain loans availed by our Company; and
4. General Corporate Purposes.

Refer to Onyx Biotec Limited RHP for more details about the Company.

Services

Equity Investment with CA Abhay

Stock Market Masterclass

FNO Stocks with CA Abhay

Equity Trading with CA Abhay

Option Trading with CA Abhay

Services

FNO Stocks with CA Abhay

Stock Market Masterclass

Equity Investment with CA Abhay

Option Trading with CA Abhay

Equity Trading with CA Abhay

onlyfans leakedonlyfan leaksonlyfans leaked videos